Minerva Surgical Inc
OTC:UTRS

Watchlist Manager
Minerva Surgical Inc Logo
Minerva Surgical Inc
OTC:UTRS
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $8.9

Wall St Price Targets

UTRS Price Targets Summary
Minerva Surgical Inc

There are no price targets for UTRS.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Minerva Surgical Inc Competitors:
Price Targets
H2A
H2APEX Group SCA
200% Upside
XO
Exotic Food PCL
33% Upside
VIBHA
Vibhavadi Medical Center PCL
5% Upside
XPEL
Xpel Inc
18% Upside

Revenue
Forecast

15% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
15% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 12%.

Gross Profit
Forecast

19% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
19% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Minerva Surgical Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Minerva Surgical Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is UTRS's stock price target?
Not Available

UTRS does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Minerva Surgical Inc?
Projected CAGR
12%

Over the last 2 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett